Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase
- PMID: 16256693
- DOI: 10.1006/bioo.2001.1214
Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase
Abstract
The posttranslational deformylation of N-formyl-Met-polypeptides by the metalloenzyme, peptide deformylase, is essential for bacterial growth. Methionine hydroxamic acid derivatives were found to inhibit recombinant Escherichia coli peptide deformylase activity containing either zinc or cobalt. The binding of methionine hydroxamate and hydrazide inhibitors to cobalt-substituted deformylase caused spectral changes consistent with the formation of a pentacoordinate metal complex similar to that of actinonin, a psuedopeptide hydroxamate inhibitor. The spectral and kinetic data support the binding of these N-substituted L-methionine derivatives in a reverse orientation with respect to N-formyl-Met-peptide substrates within the active site. Based on this hypothesis a second generation of N-substituted methionyl hydroxamic acids were evaluated and found to possess greater inhibitory potency. These results may provide the basis for the design of more potent and selective deformylase inhibitors as potential antibacterial agents.
Similar articles
-
Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.Bioorg Med Chem Lett. 2004 Dec 20;14(24):5997-6000. doi: 10.1016/j.bmcl.2004.09.087. Bioorg Med Chem Lett. 2004. PMID: 15546716
-
Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.Bioorg Med Chem Lett. 2011 Jan 1;21(1):133-6. doi: 10.1016/j.bmcl.2010.11.056. Epub 2010 Nov 16. Bioorg Med Chem Lett. 2011. PMID: 21146987
-
Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid.ChemMedChem. 2009 Feb;4(2):261-75. doi: 10.1002/cmdc.200800251. ChemMedChem. 2009. PMID: 19053131
-
Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.Curr Opin Investig Drugs. 2004 Aug;5(8):809-22. Curr Opin Investig Drugs. 2004. PMID: 15600237 Review.
-
Novel approaches to antimicrobial therapy: peptide deformylase.Curr Opin Drug Discov Devel. 2002 Sep;5(5):785-92. Curr Opin Drug Discov Devel. 2002. PMID: 12630299 Review.
Cited by
-
Targeting Metalloenzymes for Therapeutic Intervention.Chem Rev. 2019 Jan 23;119(2):1323-1455. doi: 10.1021/acs.chemrev.8b00201. Epub 2018 Sep 7. Chem Rev. 2019. PMID: 30192523 Free PMC article. Review.
-
Solvent-assisted slow conversion of a dithiazole derivative produces a competitive inhibitor of peptide deformylase.Biochim Biophys Acta. 2010 Apr;1804(4):704-13. doi: 10.1016/j.bbapap.2009.11.006. Epub 2009 Nov 14. Biochim Biophys Acta. 2010. PMID: 19922819 Free PMC article.
-
Phylogenomic and biochemical characterization of three Legionella pneumophila polypeptide deformylases.J Bacteriol. 2006 Jul;188(14):5249-57. doi: 10.1128/JB.00866-05. J Bacteriol. 2006. PMID: 16816197 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous